Concepedia

Ying-Ping Jiang

YJ

5

Publications

476

Citations

5

H-Index

2017

Active since

Affiliations

Cellerant Therapeutics (United States)(Current)

SciGenom Labs (India)

University of Virginia

Nanyang Technological University

University of Toronto

Ying-Ping Jiang is an author at Cellerant Therapeutics (United States) specializing in medicine, viral pathogenesis, and viral immunity.

Top concepts

Publications per year

2017–2021

5

Publications

5

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2

Kushal Suryamohan, Devan Diwanji, Eric Stawiski et al. · Communications Biology · 2021 · 229 citations · Full text

Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility

Eric Stawiski, Devan Diwanji, Kushal Suryamohan et al. · 2020 · 155 citations · Full text

, , +19

CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia

Ying-Ping Jiang, Bob Y. Liu, Quan Zheng et al. · Blood Advances · 2018 · 67 citations · Full text

Design and Synthesis of Isoquinolidinobenzodiazepine Dimers, a Novel Class of Antibody–Drug Conjugate Payload

Sean W. Smith, Vasu Jammalamadaka, Dmitry Borkin et al. · ACS Medicinal Chemistry Letters · 2017 · 14 citations · Full text

Surface‐Functionalized Carrier‐Free Drug Nanorods for Leukemia

Vinu Krishnan, Apoorva Sarode, Rohit Bhatt et al. · Advanced Therapeutics · 2018 · 11 citations

, , +15

Rows per page

1–5 of 5